Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > It won't be long now..

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Apr 26, 2024 12:03pm

107 Views

Post# 36009587

RE:RE:RE:RE:RE:It won't be long now..

A $10 million gain will leave you ( us) with $6.75 million net, roughly. Not bad, instead of $7.5 million prior to this new taxation.

Alamir1111 wrote: Let's calculate 10.000000 mil
6.500000 is taxable at 50 %that leaves me 3..25 mil plus3.75 mil.so o got left with 7.000000$ .I think a buy out should be at least10 billion

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario